Literature DB >> 21354767

Imagery rescripting and exposure group treatment of posttraumatic nightmares in Veterans with PTSD.

Mary E Long1, Mary E Hammons, Joanne L Davis, B Christopher Frueh, Myrna M Khan, Jon D Elhai, Ellen J Teng.   

Abstract

This study details results of an open trial of a group psychological treatment for Veterans with posttraumatic stress disorder (PTSD) and chronic posttraumatic nightmares called "Imagery Rescripting and Exposure Therapy" (IRET). IRET is a variant of a successful imagery rescripting treatment for civilian trauma-related nightmares that was modified to address the needs of the Veteran population. Thirty-seven male U.S. Veterans with PTSD and nightmares attended 6 multicomponent group sessions. Findings indicated that the intervention significantly reduced frequency of nightmares and PTSD severity, as well as increased hours of sleep. Unlike the few open trials examining treatment of nightmares in Veterans, effect sizes in this study were similar to those that have been found in the civilian randomized controlled trial. These preliminary findings suggest that a nightmares treatment can be adapted to successfully reduce distress associated with combat Veterans' chronic nightmares. Clinical and research implications are discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21354767     DOI: 10.1016/j.janxdis.2010.12.007

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  17 in total

Review 1.  Management of post-traumatic nightmares: a review of pharmacologic and nonpharmacologic treatments since 2010.

Authors:  Monica Escamilla; Mercedes LaVoy; Bret A Moore; Barry Krakow
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

2.  A meta-analysis of imagery rehearsal for post-trauma nightmares: effects on nightmare frequency, sleep quality, and posttraumatic stress.

Authors:  Melynda D Casement; Leslie M Swanson
Journal:  Clin Psychol Rev       Date:  2012-06-30

Review 3.  Sleep and Dreaming in Posttraumatic Stress Disorder.

Authors:  Katherine E Miller; Janeese A Brownlow; Steve Woodward; Philip R Gehrman
Journal:  Curr Psychiatry Rep       Date:  2017-08-22       Impact factor: 5.285

Review 4.  Treatment of Sleep Disturbances in Post-Traumatic Stress Disorder: A Review of the Literature.

Authors:  Janeese A Brownlow; Gerlinde C Harb; Richard J Ross
Journal:  Curr Psychiatry Rep       Date:  2015-06       Impact factor: 5.285

5.  Augmenting cognitive processing therapy to improve sleep impairment in PTSD: A randomized controlled trial.

Authors:  Tara E Galovski; Juliette M Harik; Leah M Blain; Lisa Elwood; Chelsea Gloth; Thomas D Fletcher
Journal:  J Consult Clin Psychol       Date:  2015-12-21

Review 6.  Sleep disturbances, TBI and PTSD: Implications for treatment and recovery.

Authors:  Karina Stavitsky Gilbert; Sarah M Kark; Philip Gehrman; Yelena Bogdanova
Journal:  Clin Psychol Rev       Date:  2015-06-03

7.  Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.

Authors:  Hollie Melton; Nick Meader; Holly Dale; Kath Wright; Julie Jones-Diette; Melanie Temple; Iram Shah; Karina Lovell; Dean McMillan; Rachel Churchill; Corrado Barbui; Simon Gilbody; Peter Coventry
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

8.  Trauma-Associated Sleep Disturbances: a Distinct Sleep Disorder?

Authors:  Tara D Rachakonda; Nadir M Balba; Miranda M Lim
Journal:  Curr Sleep Med Rep       Date:  2018-04-26

9.  Treatment of Sleep Comorbidities in Posttraumatic Stress Disorder.

Authors:  Janeese A Brownlow; Katherine E Miller; Philip R Gehrman
Journal:  Curr Treat Options Psychiatry       Date:  2020-06-12

10.  Differences in maladaptive schemas between patients suffering from chronic and acute posttraumatic stress disorder and healthy controls.

Authors:  Alireza Ahmadian; Jafar Mirzaee; Maryam Omidbeygi; Edith Holsboer-Trachsler; Serge Brand
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.